{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-011798","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.123014+00:00","generated_at":"2026-06-05T01:21:43.117974+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sanuwave Health licenses intravascular shockwave patents for $2.5M; extends debt forbearance to April 30, 2024","bullets":["Licensed intravascular shockwave patent portfolio to Vascular Wave LLC for $2.5M upfront; option to acquire for additional single-digit millions.","Noteholders consented to the license and waived related defaults; forbearance on existing defaults continued until April 30, 2024.","Patents released from NPA collateral; default rate interest continues to accrue during forbearance.","Company remains in default but avoids immediate enforcement; must still comply with all other obligations under NPA."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-011798","json":"https://secwatch.observer/filing/0001140361-24-011798.json","markdown":"https://secwatch.observer/filing/0001140361-24-011798.md","text":"https://secwatch.observer/filing/0001140361-24-011798.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124011798/0001140361-24-011798-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124011798/ef20023331_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:21:43.117974+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cc76bad0259b76bfb9b27d5a46edaf7dcb8edf5b","claim":"SANUWAVE Health, Inc. amended Consent, Limited Waiver and Fifth Amendment to Note and Warrant Purchase Agreement with NH Expansion Credit Fund Holdings LP (effective 2024-03-06).","evidence_excerpt":"On March 6, 2024, Sanuwave Health, Inc. (the “Company”) entered into a Consent, Limited Waiver and Fifth Amendment to Note and Warrant Purchase Agreement (the “Fifth Amendment”) with NH Expansion Credit Fund Holdings LP (the “Agent”) and the noteholders party thereto (the “Holders”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036124011798/0001140361-24-011798-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"NH Expansion Credit Fund Holdings LP"},{"label":"Effective","value":"2024-03-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}